Enlivex
Einat Galamidi currently serves as VP Medical at Enlivex Therapeutics since February 2022. Prior to this role, Einat held the position of Medical Director at Gamida Cell Ltd. from 2010 to February 2022. Earlier in the career, Einat worked in a biotech company from 2002 to 2010, taking on roles including Chief Technology Officer, VP of Research and Development, and Senior Researcher. Einat Galamidi earned a Doctor of Medicine (MD) degree from The Hebrew University of Jerusalem - Hadassah School of Medicine between 1995 and 2003, and also holds a Master's degree in Cancer Research & Experimental Biology from The Hebrew University of Jerusalem, completed in 2000.
This person is not in any teams
This person is not in any offices
Enlivex
Enlivex's mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell immunotherapy, Enlivex intends to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses.